Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection.

about

Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein.A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.

P2860

Q47161602-FF6FC57F-4F7E-4CA4-95B4-8B5C1A28E25A Q52350559-59221D32-5BD3-4155-B4A1-813136CA09AE

P2860

Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection.

Item

http://www.wikidata.org/entity/Q41722577

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Robust antibody and CD8+ T-cel ...... ntal rodent malaria infection.

@en

type

Item

label

Robust antibody and CD8+ T-cel ...... ntal rodent malaria infection.

@en

prefLabel

Robust antibody and CD8+ T-cel ...... ntal rodent malaria infection.

@en

P1476

Robust antibody and CD8+ T-cel ...... ental rodent malaria infection

@en

P2093

Christian Muñoz

http://www.w3.org/2001/XMLSchema#string

Emily Locke

http://www.w3.org/2001/XMLSchema#string

Fidel Zavala

http://www.w3.org/2001/XMLSchema#string

Sanjay Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Immune mechanisms of protection: can adjuvants rise to the challenge?

Viral vectors as vaccine platforms: from immunogenicity to impact

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria

High efficiency transfection of Plasmodium berghei facilitates novel selection procedures

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

The RTS,S vaccine candidate for malaria.

P2888

s41541-017-0011-y

P31

scholarly article

P356

10.1038/S41541-017-0011-Y

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dennis Christensen

Peter Andersen

Diego A Espinosa

P577

2017-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28936360

http://www.w3.org/2001/XMLSchema#string

P921

malaria

Plasmodium falciparum

P932

5603302

http://www.w3.org/2001/XMLSchema#string

Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection.

about

P2860

P2860

Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P478

P50

P577

P698

P921

P932